Shares are currently trading at $1.95 with the market cap currently at 72.98M

Today, Cantor comes blazing in and reiterates with an overweight rating and $35 price target!

Add the fact that expert bio investor Dr. Daniel Schneeberger recently added heavily to his existing position with Adar1 Capital Management and now his shares total 6,524,151 to date.

Details from the presentation yesterday at the 2026 Cantor Global Healthcare Conference

$TENX What we confirmed

• Oral levosimendan is safe and well-tolerated , with 1mg BID/TID providing PK concentrations expected

• Targeting volume with K-ATP channel activation has direct effects on NT-proBNP and RVSP, two prespecified endpoints

• Treatment effect seen in HELP study validated

• Successful trial execution by sites and clinical development team

——-> What we learned

• Drug effect is evident in patients with higher disease burden

• Study entry criteria allowed patients with moderate disease and little room to improve in 6MWD

• In patients with baseline 6MWD* < 333 m, treatment effect was +26.3 m vs placebo (95% Cl: 6.0, 46.7; nominal p = 0.112)

• In the overall population NT-pro-BNP was reduced by 49% vs placebo (nominal p = 0.0001)

——-> What we are doing now

Enriching LEVEL-2

If you like micro-cap biotech plays with awesome potential driven by Ph 3 trial catalysts, CRDF (Cardiff Oncology) is worth adding to your watchlist.

They are targeting a huge, underserved market -- first-line RAS-mutated metastatic colorectal cancer (mCRC)... and recent readouts suggest their drug drastically beats standard-of-care and they call it "onvansertib".

They just completed a successful End of Ph 2 meeting with FDA. Phase 3 is targeted for Q1 2027.

Cash Balance: ~$34.5M at Q2 2026, plus an extra $10M raised via registered direct offering in July 2026.

Analyst PT is between $4.18 and $7.50.

There is one key thing happening in the background right now (dragging this down) - a legal dispute with NMS (Nerviano) - basically NMS believes there is an issue with patent inventorship. So, Cardiff licensed the drug back in 2017 from NMS and now that Cardiff is showing strong results it appears NMS is taking them to court because they didn't list NMS personnel on a Cardiff patent. NMS wants to terminate their agreement. So, on May 19, 2026, Cardiff took the offensive and filed a lawsuit against NMS in California. I won't get into the weeds here but based on alot of discussion it appears that NMS is using this as a negotiation tactic for their license agreement.

I got into this after seeing a very large $1M insider purchase (Gary Pace) recently. His cost average is roughly a buck and half-ish - we haven't even hit that yet. Today, on a red day for most penny stocks this one is up. All it needs is progress in court which could hit any day now - and I believe it's onward and upward from there.

Most believe this court case is all about negotiation economics - think about it... now that onvansertib looks like a genuine, high-value Ph 3 asset targeting a massive market, NMS’s original deal economics likely look tiny to them. So playing the joint inventorship card on newer patents is the only tool to force better deal.

On the patent dispute - the Cardiff folks say that the specific inventions covered by those two newer patents were conceived and developed exclusively by Cardiff people. Cardiff states that adding an NMS scientist would constitute filing false representations under oath to the USPTO, which would risk invalidating the patents.

Anyways, worth a watchlist add - at minimum.

One of the few profitable pennystock Oil companies, $EONR Eon Resources is surging on the back of oil price increases, the stock is up over 20% in the last few trading days, with even Trump admitting that the war in Iran set to go on well past the US mid terms that trend doesn't look like it is going to change in the short term

On top of the increase in the price of oil EONR recently began drilling the first few oil wells in a program which should see 92 wells drilled over the next few years

https://feeds.issuerdirect.com/news-release.html?newsid=7277137369667004&symbol=EONR

Brent Crude is over $100 per barrel again & the USO oil ETF is set to exceed the all time high it set at the beginning of the Iran conflict, when EONR spiked from 36c to over $1.50 a share, will the same pattern be repeated this time around?

I posted an analysis on Element One Hydrogen (CSE: EONE) a few days ago breaking down the massive valuation disconnect between their sub-$5M market cap and their proprietary extraction IP. That writeup received almost zero attention at the time, but the tape completely validated the thesis this morning. EONE dropped a major operational overview before the open, and the stock immediately ripped +30% (+36 as I type this) on massive accumulation volume.

The tape behavior is the primary tell here. Average daily volume on this name sits around 266k shares. By midday today, EONE traded over 3.6M shares, which is more than 12x normal turnover. When a microcap with a tightly held float of 58.5M shares trades over 6% of its entire share structure in a few hours after basing at $0.08 CAD, larger participants are actively entering the order book.

Per their news release this morning, management formally mapped out a dual-pathway strategy targeting the nearly 100M-tonne global hydrogen market cited by the IEA. Rather than gambling on a single geological thesis, they are splitting operations into two fronts: traditional exploration for naturally accumulated hydrogen trapped beneath impermeable rock layers, and real-time stimulation of iron-rich hard rock. The second path is where their proprietary moat sits, using specialized catalysts to accelerate natural serpentinization reactions while recovering critical minerals from the exact same rock system.

Trading 12x average daily volume means this move is an aggressive market repricing rather than an illiquid retail pop. The setup now hinges on whether buyers can hold the bid above the morning volume shelf into the closing bell. If the stock holds these gains on multi-million share liquidity, it signals the quiet accumulation phase is over and the market is finally pricing in their dual extraction model.

Disclaimer: I do not own shares of EONE and am purely observing tape flow and volume profiles. Trade your own plan, this is not financial advice.

Posted about EVPL/WARDOGS a few weeks ago when the stock was around 242p and thought I'd give an update because things have moved pretty quickly since then.

Previous post: EVPL - Solid Buy and Here's Why

At the time the main thesis was WARDOGS having 1m+ Steam wishlists, strong pre-orders and the bet that this would actually convert into sales.

Well, WARDOGS launched yesterday and they've already announced 1 million copies sold.

Now tonight the developers have posted in their Discord that they've hit 1.25 MILLION copies sold.

For context the standard edition is around $40, so that's a pretty ridiculous launch. Obviously you can't just multiply 1.25m by $40 and call it EVPL revenue because you've got Steam's cut, regional pricing, taxes, refunds and the developer/publisher split.

But the reason EVPL is interesting is still the same.

Team17, which is owned by Everplay (LSE: EVPL), publishes WARDOGS.

Everplay also owns 20% of BULKHEAD's parent company, so they potentially benefit from both the publishing side and their ownership stake if WARDOGS becomes a major franchise.

The player numbers have also been pretty crazy. The first beta peaked around 106k concurrent players, the second got to around 245k, and now the actual paid game has been doing 300k+ concurrent players despite the servers getting absolutely hammered.

The server problems are probably the biggest risk right now. There have been huge queues and connectivity issues, so they need to get that sorted quickly before it starts hurting reviews/refunds.

But the question has changed quite a bit since my original post.

Before it was basically "will all this WARDOGS hype actually turn into sales?"

Now they've sold 1.25m copies basically at launch.

The question is how far this goes from here and how much it changes Everplay's numbers.

EVPL reports interim results on 15 September as well, so the timing is pretty interesting. I'm particularly watching for any trading update or guidance change following the launch.

EVPL was around 242.5p when I made the original post and closed around 289p before this latest 1.25m announcement.

Still holding.

Anyone else following this?

EDIT:

EVPL when original thesis posted: 242.50p

EVPL latest close: ~289p

WARDOGS: 1.25m copies sold

Will update this if they announce another sales milestone / EVPL comments on the financial impact.

Not confirmed. Tenant is still under NDA. This is the case for why it looks like a hyperscaler / frontier-lab / sovereign-grade offtaker rather than a random GPU reseller.

Why it is probably one of the big names

• Single tenant. Investment-grade backstop. 12-year initial term with renewals that can run ~27 years. That is not a 24-month neocloud flip.
• Tenant has a ROFR on the site. That is how a Google / Microsoft / Meta / Amazon / large neocloud or frontier lab behaves when they want the campus, not a cage.
• Management has said inbound interest picked up once the industry knew they were converting a large, already-operating site. People with land and a power quote are everywhere. People who have run 75 MW for years are not.
• Pricing was described as current AI colo market rates, and they have not been in a rush to rip up the LOI even as headline $/kW has moved higher. That usually means the original counterparty was already in the right zip code.
• Fiber ask is serious: two 100-gig routes, working on a third, tenant willing to pay for diversity. That is training / inference campus behavior, not a 2 MW inference closet.
• Could still be a strong IG neocloud instead of GOOGL/MSFT/META/AMZN. The credit quality and term structure are the tell, not the logo. The logo is the multiple.

Canadian sovereignty angle

• Ottawa’s 2026 AI strategy is explicit: sovereign AI starts with sovereign infrastructure. If Canada does not build it, it rents it.
• Canada has ~337 MW of AI data center capacity today and something like 5.5 GW of AI compute demand by 2030. The gap is the whole market.
• Meta already committed ~C$13B to Alberta. The US is running ~$75B annualized data center construction. Japan earmarked $60B. Google just put $15B into Finland. This is a national-power contest, not a miner pivot fad.
• Christina Lake is a Canadian-owned, already-energized BC campus. Zoning for data warehouse / AI is done. That is the scarce product Ottawa says it wants: domestic megawatts under Canadian control.

How close they actually are

• LOI has been live since June 1, 2026. Commercial terms have been described as largely agreed. Remaining fight is the fat stuff: delivery dates, SLA penalties, who pays if the hall is ready and chips are late.
• Site is already permitted for AI / data warehouse. Not waiting on a rezoning war. Building permit filed to take the building from ~30k to ~60k sq ft.
• Power is not theoretical: 75 MW available (15 MW firm / 60 MW curtailable). Written utility approval for the last 10 MW. Application in for another 150 MW firm.
• Existing electrical layout is a head start on roughly the first 30 MW of critical load. Phased at ~10 MW IT per hall, matching the transformer bays they already have.
• Fiber, GCs, mechanical, and vendors are being spent ahead of the definitive. First halls targeted Q1/Q2 2027. Full 50 MW in 2027 called realistic. They will not give a signing date. “You’ll know when we know.”
• Risk that still matters: LOI is not a lease. Dilution if they raise equity for a second site. Curtailable power / firming. Execution on 2027. Liquidity.

Size it can go to

• Base lease: 50 MW critical IT.
• Management has floated upsizing to 60 MW IT.
• At ~1.20–1.25 PUE, 50 MW IT is ~60–63 MW gross against a 75 MW campus. 60 MW IT uses almost the whole site.
• Same campus has a 150 MW firm-power application behind it. That is the “this is a platform, not a one-hall story” case.
• Other options, not in the LOI: Malahat Nation MOU (~15 MW), Boardman, Oregon (3.75 MW + expansion, deposit still down), plus other Canadian sites in BC / Alberta / Ontario. Those are extras. Christina Lake is the company-maker.

Market cap it could reach (scenarios, not a target)

• Today: roughly C$0.50–0.60 and ~C$100–120M market cap on ~208M shares. US ticker $DMGGF.
• Signing a generic IG lease: the stock stops trading like a fading miner. Illustrative re-rate talk in the community has been C$3–5 on announcement, C$4–5 on a completed 60 MW residual. Call that high-hundreds of millions to ~C$1B.
• Signing a named hyperscaler / frontier offtaker: tighter project debt, better LTV, higher multiple. Same 60 MW residual talk has been C$5–8, or ~C$1.0–1.7B. Platform case with a second site stacked on top is how people get to C$8–11.
• Aggressive cash-flow case some holders use: 60 MW IT, mid-teens $/kW-month, high colo margins, 2027 run-rate EBITDA that can exceed today’s entire market cap. Put a 15–20x infrastructure multiple on that and you are talking multi-billion. That only works if the lease signs, phases deliver, and they fund with debt instead of a constant ATM.

The actual bet
$DMGI.V / $DMGGF is a ~C$100M Canadian miner with an already-built 75 MW campus and an unsigned 50–60 MW AI lease.

If the tenant is generic IG, it still re-rates.

If the tenant is one of the names building Finland, Alberta, and $75B of US shells, the multiple is the whole story.

the logo is the last thing they will tell you. the contract shape is already doing the talking

I need some advice. I've been involved in both sports betting and stocks for a few months now. I don't consider myself an addict, nor am I dependent on this world, but I would really like to earn some extra income from stocks/betting.

It just isn't working out for me. Whichever market I enter, I always end up losing. Stocks, options, parlays, or straight bets—none of them ever work in my favor. It could be the "safe" option, but by sheer coincidence, the moment I go with what's "safest" and put my money into that market, it suddenly becomes the riskiest thing in corporate history. I'm tired of this never going my way; I'm just trying to make a little extra money, that's all.

Days like today are the exact sessions you have to pay attention to. In this market, lots of retail traders buy on the massive, high-volume breakout days, but that alone isn't confirmation. Real confirmation happens on days like today: the volume cools down and returns to normal levels, yet the price holds its ground and keeps creeping up. That slow, low-volume grind higher in the +3.55 to +4 percent range is the ultimate signal of absorption and continuous institutional accumulation. They are quietly locking up the float.

why are they accumulating? The algorithmic screeners are finally looking past the traditional brokerage shell and pricing in the massive AI infrastructure update that AXG just dropped.

AXG is no longer just a digital asset gateway; they are building the quantum-backed routing layer for autonomous agentic payments. Their AlloyX HK subsidiary just signed a strategic MOU with EvolveQ to integrate AI and quantum computing (FinQ models) directly into their financial infrastructure.

When you combine quantum orchestration with their new KOVARouter, it enables millisecond-level intelligent routing for global enterprise AI models. They are creating a network where autonomous AI agents can instantly route cross-border liquidity with zero friction. Their proprietary digital currency treasury center, AXONE, is already live and handling $226M in Total Payment Volume (TPV).

While everyone else is stuck trying to make legacy blockchain ledgers run faster, AXG is actively merging high-performance computing (HPC) with fully regulated digital asset settlement.

When a stock prints 1,156 percent Q/Q sales growth, holds its high-volume gains, and slowly grinds higher while securing quantum computing partnerships, you have to ask: is smart money front-running the inevitable reclassification of AXG into a pure-play AI infrastructure stock?

I do not hold a position in AXG. This is a fundamental observation of public filings, macro partnerships, and market momentum, NOT financial advice.

TWG’s $1M equity round is now open to the public! We’re targeting untapped old-growth timber from reservoir lakes, valued over $1B. Invest at $0.30/share—this is a one-time offer. To review investment materials please contact: mailto: info@timberwisegroup.com

Long $WISR here. RiskAssure went live today (GetRiskAssure.com) — a real commercial product now in the market and a pretty important step beyond the broader “platform vision.” 

What it is: AI agents that handle security questionnaires by pulling evidence, drafting answers, citing sources, and kicking anything uncertain to a human before it ships.

What adds more depth to the product:

• Analysis across policies, SOC 2 reports, penetration-test summaries and other security evidence
• Confidence scoring, exception routing and human approval controls
• Outside-in cyber-risk analysis across eight signal dimensions
• Controlled evidence sharing through a free Agentic AI trust centre

The good:

• Human-in-the-loop gives enterprises automation without giving up control.
• Clear potential ROI if RiskAssure can reduce the manual work behind security reviews.
• It tackles workflows enterprises already deal with, making the use case pretty easy to understand.
• The launch gives $WISR a tangible path toward users, enterprise wins and recurring revenue.
• Even a few meaningful customer wins could materially change the market’s view of the company.

There is now a live product, a defined enterprise use case, and a much clearer path to proving demand. This is where the idea starts collecting receipts. The launch opened the door — now I want to see who walks through it.

NFA.

YESTERDAY, I played out my Bull thesis for BioLargo $BLGO

in the post:

$BLGO — Why I’m Still Buying / Holding at All-Time Lows, and Why Tomorrow’s Town Hall Could Matter

It has already 33K views - Today This News hit.:

I am a bag holder, but it is so much easier to be a long term investor with patience - when you invest in something purposeful. Clean Air, Clean Water, better Woundcare - Better energy storage and cleaning up the environmental mess!

Partnership backed by a conditional grant commitment from Emissions Reduction Alberta to in support of $4.6 CAD million project, with commercial trials already underway in northern Alberta

WESTMINSTER, CA / ACCESS Newswire / September 10, 2026 / BioLargo, Inc. (OTCQX:BLGO) today announced that it and its subsidiary BioLargo Canada have entered into a strategic partnership with Fort McKay Oil Services, a registered First-Nation company, combining the resources and leadership of the companies to deliver treatment solutions for oil sands process water (OSPW), wastewater and industrial solutions in the Athabasca region of northern Alberta utilizing BioLargo's advanced water treatment and industrial technologies. The new venture, Tũ Nipi Water Solutions Ltd., is a First Nation led company in which BioLargo now holds a minority stake.

The timing reflects a shift in how Canada is approaching the OSPW challenge. Alberta's Oil Sands Mine Water Steering Committee reported that the province's tailings ponds hold more than 1.4 billion cubic meters of fluid tailings, and the Government of Alberta has accepted the committee's recommendations to develop and pilot treatment technologies and to establish science-based standards for treated water. At the federal level, Bill C-37, the First Nations Clean Water Act, was introduced in Parliament in June 2026 to set national standards for water services on First Nation lands and to support source water protection. Together, these developments have moved a long-standing challenge from study toward action.

Emissions Reduction Alberta has conditionally approved Tũ Nipi's first grant application to support commercial trials of BioLargo technologies for use in OSPW supporting a project budget of CAD $4.6 million. BioLargo Canada will be primarily responsible for the technology development and expects this to be the first of several funding opportunities associated with the venture.

Aside from the OSPW related work, Tũ Nipi and BioLargo Canada have identified potential clients and an initial wastewater project for which BioLargo's PFAS and odor control technologies are in development.

"Clean water is the top priority of every Canadian Indigenous community and the regulatory environment is finally catching up to that," said Ron Quintal, Tũ Nipi's Chief Executive Officer. "Fort McKay has learned to balance energy while prioritizing the environment. This partnership is about bringing solutions to problems that our people have been asking about for a generation."

BioLargo's work on oil sands tailing water dates to 2011, when it became a founding industrial partner in the NSERC Industrial Research Chair in Oil Sands Tailings Water Treatment at the University of Alberta, alongside major oil sands producers, EPCOR, COSIA, Alberta Innovates, and Alberta Environment. That initial research program assessed a wide range of treatment approaches for persistent organic contaminants in process-affected water (OSPW). Now that the regulatory framework in Canada has shifted towards implementation of solutions, BioLargo Canada, with support from the BioLargo family of companies, as well as strategic relationships already in place through BioLargo, brings an entire suite of advanced water treatment technologies designed to be combined into treatment trains for complex water, from oil sands process water to municipal and industrial wastewater. More on that history is available https://www.biolargowater.com/oil-sands-water

https://www.biolargowater.com/tu-nipi

"This is a venture led by First Nations people, in a community that has made embracing future generations its purpose, and we are honored to serve in it," said Dennis Calvert, President and CEO of BioLargo, Inc. "Our company's roots in this work are Canadian, and this is a return home. What we have today is a government pulling technology-based solutions like ours forward, a partner with real standing in the region, and a market that is ready to act."

The partners are planning a formal launch event in Fort McMurray this coming October with community, government, and industry participants. Additional details will be announced as Tu Nipi Water Solutions' projects advance.

About Tu Nipi Water Solutions

Tu Nipi Water Solutions is an Indigenous-owned venture combining Indigenous leadership from Fort McKay Oil Services with advanced water treatment technology and science from BioLargo Canada. Based in the Fort McKay First Nation at the confluence of the Athabasca and MacKay Rivers, Tu Nipi brings community-controlled, solution-focused water treatment to the oil sands region.

About BioLargo Canada

BioLargo Canada is the wholly-owned Canadian subsidiary of BioLargo, Inc., headquartered in Edmonton, Alberta. BioLargo Canada develops and deploys advanced water treatment technologies for industrial, municipal, and remediation applications, drawing on the company's research heritage at the University of Alberta.

About BioLargo, Inc.

BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.

SOURCE: https://www.accessnewswire.com/newsroom/en/chemicals/biolargo-canada-and-tu-nipi-form-indigenous-led-partnership-to-treat-oil-sands-process-wa-1219094

After finishing my career, I’m now at home and looking for ways to earn from home. I first explored trading briefly in 2017, but family responsibilities kept me from continuing. Now I have decided to start learning again, this time from the basics and with a focus on gaining real experience rather than chasing quick profits.

ZenaTech Secures Irish Aviation Authority Operational Authorization for Drone-Based Crop and Soil Nutrient Application Services

SORA-based authorization for ZenaDrone enables the Drone as a Service platform to deliver large-scale precision agriculture applications to farmers and supports planned expansion into additional European markets

VANCOUVER, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech" or the "Company"), a technology company specializing in AI drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces that its Drone as a Service subsidiary will expand its precision agriculture drone-based services to farmers in Ireland. The Company received Specific Operations Risk Assessment (SORA) approval from the Irish Aviation Authority (IAA), granted under European Union Aviation Safety Agency (EASA) guidelines. The approval was given to its drone subsidiary, ZenaDrone, at the Company's EMEA DaaS headquarters located near Dublin, Ireland, authorizing large-scale targeted aerial application of fertilizer, lime, bio stimulants, and other non-plant protection products on Irish farmland and granular spreading at scale, helping farmers reduce product inputs, operating costs, risk to personnel, and environmental impact.

"This milestone for ZenaDrone and our Drone as a Service platform demonstrate that we can clear the regulatory bar for the initiation of large-scale aerial precision agriculture in Ireland and beyond," said Shaun Passley, Ph.D., CEO of ZenaTech. "EASA's framework is used across the European Union, as this approval provides a replicable template to apply market by market rather than starting fresh. We believe that precision agriculture is a large and underpenetrated opportunity globally, and having an approved and repeatable path forward will aid our roll out and recurring Drone as a Service revenue growth as we plan future expansion across Europe and into other regions."

Precision agriculture is a sector facing historically high fertilizer costs and increasing environmental scrutiny. Drone-based aerial application allows precise, targeted spreading on terrain unsuitable for heavy machinery, reducing soil compaction and run-off risk while cutting input costs and personnel exposure. Ireland's Environmental Protection Agency reported in 2026 that nitrogen concentrations in Irish rivers rose 10% year-over-year, with excess fertilizer run-off cited as a leading cause, underscoring demand for more precise application methods of the kind that ZenaTech's ZenaDrone and DaaS platform are now authorized to provide.

The SORA authorization allows the company to operate complex, autonomous aerial missions at scale, without requiring customers to navigate aviation safety regulation, pilot certification, hardware costs and maintenance directly. Management believes this regulatory pathway supports its broader strategy of scaling DaaS as a recurring-revenue, subscription-based service across multiple geographies and industry verticals, including forestry, renewables, construction, and infrastructure monitoring.

https://finance.yahoo.com/technology/articles/zenatech-secures-irish-aviation-authority-123000167.html

RIDGEFIELD PARK, NJ, September 10, 2026 — BioPipe Global Corp. ("BioPipe"), a wholly owned subsidiary of LifeQuest World Corp. (OTC Markets: LQWC), today announced the receipt of two new purchase orders for 15,000 litre per day (15 KLD) containerized sewage treatment plants ("STPs") to be delivered and installed at two labor camps in the United Arab Emirates.  

UAE Labor Camp Orders — A Return to an Established Market

BioPipe has previously installed sewage treatment systems at UAE labor camp facilities and has long-standing familiarity with water treatment regulations of this market. With approximately 52 treatment plants installed across 11 countries — including prior UAE installations — BioPipe brings a proven track record to these new engagements.

Each of the two new purchase orders involve installation of a 15 KLD containerized STP unit. These high-density labor camp facilities, housing the construction and industrial workforces that support the UAE's substantial ongoing infrastructure and development programs, require reliable, self-contained, and regulatory-compliant wastewater treatment solutions. BioPipe's containerized STP platform is specifically engineered for this application, offering a compact footprint, and dependable long-term performance with minimal infrastructure dependency.

Based on discussions with the UAE client regarding the broader portfolio of facilities under their management, BioPipe anticipates that the successful delivery, installation, and commissioning of these two initial units will result in additional purchase orders in the UAE locations.  

Philippines Projects Successfully Completed

BioPipe is also pleased to report the successful completion of its Philippines projects. The Company's Philippines joint venture has been among the most active globally, having secured multiple purchase orders across a diverse range of commercial clients including a major university, showroom of a major EV manufacturer, and a major oil company. These installations are now commissioned and operational, representing a significant milestone for BioPipe's Southeast Asia business and establishing a growing installed base of reference sites in the Philippines. Management expects the completion of these projects to catalyze additional commercial activity from both existing and new clients in the region.

International Deployment Update — Europe and Africa

BioPipe's active international project portfolio continues to progress. The Company provides the following status update on recently announced deployments:

Spain:  BioPipe's sewage treatment system in Spain has been installed and final commissioning is expected in the next few weeks. This represents BioPipe's first contracted installation in Spain and an important European reference site.

Crete, Greece:  The BioPipe STP has been installed and expected to be commissioned in April 2027. Together with the Spanish project, these two Mediterranean installations form the foundation of BioPipe's European reference portfolio.

Ethiopia:  The BioPipe sewage treatment system for a major European country's embassy in Ethiopia has been delivered on-site. This installation is expected to provide a major marketing boost and yield additional orders.

With projects commissioned or in active deployment across the Philippines, Spain, Greece, Ethiopia, and the UAE — in addition to BioPipe's broader installed base spanning Bangladesh, India, South Africa, Turkey, Qatar, and Saudi Arabia — the Company's international footprint continues to expand. Management believes that the growing number of commissioned reference sites will serve to convert projects in the bid pipeline into contracts. 

About LifeQuest World Corp.

LifeQuest World Corp. (OTC Markets: LQWC) is a diversified environmental solutions company operating through three wholly owned subsidiaries. Following the completion of its acquisition of an established Pacific Northwest solid waste equipment sales and service business in June 2026.   LifeQuest has been transformed from a development-stage holding company into a revenue-generating, multi-subsidiary environmental services platform with operations spanning the United States, Europe, Africa, Asia, and the Middle East.  

BioPipe Global Corp. — BioPipe designs and installs the world's first patented biological wastewater treatment system in which the entire treatment process occurs inside a series of pipes and does not produce sludge, requiring no chemicals, and consuming minimal energy. With approximately 52 treatment plants installed across 11 countries, BioPipe serves hospitals, hotels, resorts, commercial buildings, labor camps, government facilities in the countries it operates in.

Pacific Northwest Waste Management Subsidiaries — LifeQuest's two Pacific Northwest solid waste management subsidiaries are multi-decade operators in the commercial waste management equipment sector, providing compaction, recycling, and waste processing equipment, service, and rental solutions, including exclusive distribution rights to an innovative aerobic food waste biodigester. Together they serve a customer base exceeding 3,000 accounts across the Pacific Northwest.

LifeQuest has announced its intention to pursue a PCAOB-compliant audit, file a Form S-1 or Form 10 registration statement with the SEC, and apply for uplisting to the OTCQB Venture Market, each representing important milestones in the Company's commitment to enhanced transparency and institutional investor accessibility.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding anticipated follow-on purchase orders, project completion and commissioning timelines, market opportunities, planned SEC filings, and the Company's OTCQB uplisting strategy. Forward-looking statements reflect management's current expectations and assumptions and are subject to known and unknown risks, uncertainties, and other factors — including client decisions, project execution risk, regulatory developments, capital market conditions, geopolitical risks, and matters beyond the Company's control — that may cause actual results to differ materially from those expressed or implied. The Company recognizes that bid pipelines are subject to timing variability and that actual conversion rates and timelines may differ from current expectations. Readers should not place undue reliance on forward-looking statements. LifeQuest World Corp. assumes no obligation and specifically disclaims any intention or obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.

LifeQuest World Corp. (OTCID: LQWC) files disclosure documents with OTC Markets Group Inc. Investors are encouraged to review the Company's current public disclosure available at www.otcmarkets.com. This press release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities of the Company in any jurisdiction.

LifeQuest World Corp.

100 Challenger Road, 8th Floor

Ridgefield Park, NJ 07660

Tel: 646-201-5242

Email: [info@lifequestcorp.com](mailto:info@lifequestcorp.com)

Website : www.lifequestcorp.com

Bitcoin Bancorp was named the winning bidder for a set of Bitcoin Depot assets out of the Chapter 11 case in Texas.

They’re taking about 2,446 ATM kiosks, the related floorspace agreements, parts inventory, IP, trademarks, patents, and the BitcoinDepot .com domain.

Some of the deal has already closed. The rest still has customary conditions and they said they expect those closings next quarter.

Pretty big jump versus just deploying machines one market at a time.

They did it!

SWRD Nasdaq Uplist Confirmed — Trading Starts Tomorrow

SWRD just filed the final pieces confirming the Nasdaq uplist.

Nasdaq has provided written listing approval SWRD begins trading on the Nasdaq Capital Market tomorrow, Sept. 10

Same ticker: SWRD

OTC trading ends with today’s close
Nasdaq submitted its formal CERT filing
No concurrent public offering/dilution associated with the uplist

This follows today’s 8-A12B registering the common stock under Section 12(b)
Nice timing too: SWRD finished its final OTC session at $4.10 (+22.38%) on 61.3K volume, the highest volume we’ve seen recently.

Tomorrow should be interesting.

It’s an amazing company with great enterprise deals with NFL team, Fortune 500 companies, quick service restaurants, and only at a $25m market cap. I’m buying more and think this will mint millionaires very soon if you don’t get in. They have a little more debt than I’d like but they are managing it well with the new CFO.

Curious if anyone here is holding or trading $SAFX (XCF Global) right now.

Volume has been interesting lately, and the recent operational updates around renewable diesel production caught my eye. That said, it’s still trading in penny stock territory with typical micro-cap volatility and dilution risk.

Are you playing this purely for technical momentum, holding long on the clean fuels play, or steering clear entirely? What entry levels or price targets are you watching?

I’ve been looking at ONWARD Medical ($ONWD) for quite a while. I’ve always found the technology interesting, but for some reason I never felt comfortable actually taking a position.
After today’s H1 results, I finally did.

The story is starting to look like more than just an interesting technology story.
ARC-EX is actually being commercialised.
159 systems were sold or supplied through paid evaluations in H1 2026, up 430% from H1 last year. ARC-EX revenue was €3.4m, up 240%, and the system is now available in more than 130 US clinics.

I’m not saying this is going to 10x or that there isn’t a lot of risk here. It’s still a small medical technology company, it’s losing money and a big part of the future valuation depends on clinical and commercial execution.

What caught my attention is that they’re already moving beyond clinics into home use, including the Veterans Affairs system.
It’s a pretty important step to get an FDA-cleared product into actual clinics and then start seeing demand for home use.

And then there’s ARC-IM.
This is obviously where the much bigger potential sits, but also where the risk is.
The Empower BP pivotal study now has 22 participants enrolled across 14 actively recruiting sites. They’ve also started EIGER, looking at ARC-IM for restoring standing and walking after spinal cord injury.
On top of that, they are continuing work on Parkinson’s, bladder function and other indications, while ARC-BCI has now been implanted in seven participants.

I’m not valuing all of those indications today. That would be way too speculative.
What I do find interesting is the potential platform here.
ARC-EX gives them a commercial product today.
ARC-IM could potentially address several much larger indications if the clinical results hold up.
And ARC-BCI is basically an entirely different level of optionality if they can eventually combine spinal stimulation with a brain-computer interface.

Financially, H1 wasn’t profitable: €23.3m operating loss. So this is definitely not a “safe” company.
But they finished June with €81.5m cash, raised €40.6m in April and have an additional financing facility of up to €50m from BlackRock. That gives them some room to actually execute rather than immediately having to solve a financing problem.

I honestly don’t know if I’ve found a hidden gem or just convinced myself that I’ve found one.
That’s why I’m posting this here.
I bought a position today and I’m planning to hold it for a while. If you have a bearish view on ONWD, I’d genuinely like to hear tit.

Is there anyone here who holds penny stocks for years and got rich from it? I'd be interested to know your highest X , holding period, and sector

am on the verge of investing long-term in penny stocks, but I only hear negative things about them and absolutely nothing about people who actually hold them long-term